Farrell Michael J. 4

What Happened

• Michael J. Farrell, a member of the Board of Directors of Zimmer Biomet Holdings, Inc. (ZBH), received an award of 432.776 phantom stock units on June 30, 2026. The reported acquisition price is $0.00 because these are derivative units (phantom shares) rather than an open-market purchase of common stock.

Key Details

• Transaction date: 2026-06-30; Form 4 filed: 2026-07-02 (appears timely, two business days after the transaction).
• Security: 432.776 phantom stock units (derivative security); reported price $0.00; Conversion/Exercise ratio: 1-for-1 (Footnote F2).
• Settlement: Units are to be settled in cash in a lump sum within 60 days after the reporting person stops serving as a director (Footnote F3).
• Plan: Units were accrued under the Zimmer Biomet Deferred Compensation Plan for Non-Employee Directors (Footnote F1).
• Shares owned after transaction: not specified in this filing.

Context

• These are deferred compensation awards for a non-employee director, not an outright purchase or sale of common stock. The units represent a future cash payment tied to the company’s stock (settled in cash), so their present reported value is $0 but actual payout will depend on the company’s stock value at settlement. Such awards are routine for directors and do not by themselves indicate a buy/sell signal.